Applied DNA And Alphazyme Conclude Linea RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement In Linea IVT Platform Economics
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences (APDN) and Alphazyme have successfully concluded a project to scale up the manufacturing of Linea RNAP, resulting in significant economic improvements for the Linea IVT platform.
June 20, 2024 | 1:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences (APDN) and Alphazyme have completed a project to scale up the manufacturing of Linea RNAP, leading to substantial economic improvements for the Linea IVT platform.
The successful scale-up of Linea RNAP manufacturing is likely to improve the cost efficiency and profitability of APDN's Linea IVT platform, which should positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100